GLP-1 Drugs Cut Addiction Risk and Overdose Deaths Across Six Substances
A 600,000-person study finds semaglutide and other GLP-1 drugs reduce substance use disorders by up to 25% and lower overdose deaths.
20 articles
A 600,000-person study finds semaglutide and other GLP-1 drugs reduce substance use disorders by up to 25% and lower overdose deaths.
New analysis reveals certain GLP-1 medications show increased reports of muscle atrophy compared to other drugs.
Plant-based compounds from mango, bitter melon, and apple show promise for managing early blood sugar problems before diabetes develops.
Thomas DeLauer explains how psyllium husk forms a gel barrier in your gut to physically slow glucose absorption and improve insulin sensitivity.
Stanford researchers found genetic variants in ~10% of people that blunt GLP-1 drug effectiveness, pointing toward precision diabetes care.
With 225+ clinical trials behind it, intermittent fasting rivals calorie restriction for type 2 diabetes — yet major guidelines still ignore it.
A novel β2 agonist pill boosts fat burning via skeletal muscle, preserving muscle mass while improving blood sugar in early trials.
Research on Japanese flounder identifies a key protein that regulates glucose metabolism and insulin signaling pathways.
12-week study shows sodium butyrate enhanced weight loss in obesity and improved glucose control in type 2 diabetes patients.
New research reveals genetic 'GLP-1 resistance' affects 1 in 10 people, explaining why popular diabetes and weight-loss drugs fail for some patients.
New research reveals why high-intensity interval training outperforms moderate cardio for insulin sensitivity.
Research shows maple syrup's unique antioxidant compounds may improve insulin sensitivity and reduce harmful visceral fat accumulation.
An fMRI study reveals low-calorie sweeteners like monk fruit and sucralose trigger distinct reward-area brain responses compared to sugar.
Experts say the next era of obesity care pairs GLP-1 medications with precision medicine, endoscopic procedures, and surgery for lasting results.
CGM data reveals infants fed corn syrup solid-based formulas show significantly greater glycemic variability than those fed breast milk or lactose-based formula.
ZOE's Head Nutritionist explains the science of hunger, GLP-1 drugs, and the nutrition strategy that protects muscle and gut health.
New research reveals how liver-focused strategies can improve insulin sensitivity while still eating carbohydrates.
Research reveals how this ancient spice's unique amino acid helps regulate insulin naturally without dangerous blood sugar crashes.
Discover how dietary fiber triggers gut bacteria to produce compounds that naturally increase GLP-1 and reduce hunger hormones.
New research reveals how fermentation transforms bread's metabolic effects, potentially reducing insulin resistance and digestive issues.